Literature DB >> 9727958

Development of new vaccines for tuberculosis. Recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET).

.   

Abstract

Tuberculosis (TB) remains a major, global public health problem, particularly in low-income countries. Better application of current diagnostic, treatment, and prevention strategies could lead to gradual decreases in the disease, but eliminating TB completely in the United States and internationally will require new tools. The greatest impact could come from a new vaccine, and recent technological advances have provided the basis for new vaccine development. However, sustained support is required to move the research from the laboratory to field trials of vaccines and to implement new vaccine programs. Recognizing the importance of TB vaccines, the Advisory Council for the Elimination of Tuberculosis (ACET) recommends that public agencies and vaccine manufacturers develop a comprehensive, consensual strategy to achieve these goals. This report outlines the elements that should be considered in devising a strategic plan for vaccine development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727958

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  7 in total

1.  Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

Authors:  A Weinrich Olsen; L A van Pinxteren; L Meng Okkels; P Birk Rasmussen; P Andersen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Mycobacterium tuberculosis-secreted protein antigens: immunogenicity in baboons.

Authors:  K Pehler; K M Brasky; T M Butler; R Attanasio
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

Review 3.  [Immunization: leaps into the future. Tuberculosis vaccines].

Authors:  N Martínez Alsina; R Sastre de la Fuente
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

4.  Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA.

Authors:  Jennifer L Taylor; Diane J Ordway; Jolynn Troudt; Mercedes Gonzalez-Juarrero; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Tuberculosis 2004: challenges and opportunities.

Authors:  Jeffrey Glassroth
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

6.  Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settings.

Authors:  Marissa Renardy; Denise E Kirschner
Journal:  J Theor Biol       Date:  2019-03-06       Impact factor: 2.691

7.  Immunogenicity and safety of Mycobacterium tuberculosis culture filtrate proteins in non-human primates.

Authors:  R Attanasio; K Pehler; H M McClure
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.